Kangmei Pharmaceutical’s Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2025
Securities code: 600518 Securities abbreviation: Kangmei Pharmaceutical Announcement number: 2025-042
Kangmei Pharmaceutical Co., Ltd.
Notice on convening the second extraordinary general meeting of shareholders in 2025
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Date of shareholders’ meeting: December 26, 2025
The online voting system adopted for this shareholders’ meeting: Shanghai Stock Exchange Shareholders’ Meeting Online Voting
system
1. Basic information on convening the meeting
(1) Type and session of shareholders’ meeting
The second extraordinary general meeting of shareholders in 2025
(2) Convener of the general meeting of shareholders: Board of Directors
(3) Voting method: The voting method used in this shareholders’ meeting is a combination of on-site voting and online voting.
way of combining
(4) Date, time and place of on-site meeting
Date and time of the meeting: 14:30 on December 26, 2025
Venue: Traditional Chinese Medicine Production Base No. 2 of Kangmei Pharmaceutical Co., Ltd., Science and Technology Industrial Park, Puning City, Guangdong Province
Phase 1 comprehensive building conference room
(5) Online voting system, start and end dates and voting time.
Online Voting System: Shanghai Stock Exchange Shareholders Meeting Online Voting System
Online voting starts and ends on December 26, 2025
Until December 26, 2025
Using the Shanghai Stock Exchange's online voting system, the voting time through the trading system voting platform is the trading time period on the day the shareholders' meeting is held, that is, 9:15-9:25, 9:30-11:30, 13:00-15:00; the voting time through the Internet voting platform is 9:15-15:00 on the day the shareholders' meeting is held.
(6) Voting procedures for margin trading, securities lending, refinancing, agreed repurchase business accounts and Shanghai-Hong Kong Stock Connect investors
Voting involving accounts related to margin financing and securities lending, refinancing business, agreed repurchase business, and Shanghai-Hong Kong Stock Connect investors should be conducted in accordance with the "Shanghai Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operations"
"Work" and other relevant regulations shall be implemented.
(7) Involving public solicitation of shareholder voting rights
None
2. Matters to be considered at the meeting
Proposals to be considered at this general meeting of shareholders and types of voting shareholders
Voting shareholder type serial number Proposal name
Non-cumulative voting resolution for A-share shareholders
1 "Proposal on canceling the Board of Supervisors and abolishing the "Procedural Rules of the Supervisory Board" √ 2 "Proposal on amending the "Articles of Association" √ 3 "Proposal on amending the "Rules of Procedures of the General Meeting of Shareholders" √ 4 "Proposal on amending the "Rules of Procedures of the Board of Directors" √ 5 "Proposal on amending the "Independent Director System" √ 6 "Proposal on amending the "Related Transaction Management System" √ 7 "Proposal on amending the "Related Transaction Data Statistics System" √ 8 "Proposal on Amending the "External Investment Management System" √ 9 "Proposal on Amending the "External Guarantee Management System" √ 10 "Proposal on Amending the "Raised Funds Management System" √ 11 "Proposal on Amending the "Cumulative Voting System Implementation Rules" √ 12 "Proposal on Amending the "Internal Accountability Management System for Securities Violations and Violations" √ 13 "Proposal on Amending the "Accounting Firm Selection and Recruitment System" √ 14 "Proposal on the Establishment of the "Remuneration Management System for Directors and Senior Management Personnel" √ 15 "Proposal on the Establishment of the "Resignation Management System for Directors and Senior Management Personnel" √ 16 "Proposal on the Electing of Ms. Yu Yuying as an Independent Director" √
- The time and disclosure media of each proposal
For details of Proposals 1-16, please refer to the relevant announcements and documents disclosed by the company on the same day in China Securities Journal, Shanghai Securities News, Securities Daily, Securities Times and the Shanghai Stock Exchange website (www.sse.com.cn). At the same time, the company will disclose the "Kangmei Pharmaceuticals 2025 Second Extraordinary General Meeting of Shareholders Meeting Materials" on the Shanghai Stock Exchange website before this shareholders' meeting.
Special Resolution Proposal: Proposal 2
Proposal on separate counting of votes for small and medium investors: Proposals 1-16
Proposals involving related shareholders’ avoidance of voting: None
Name of related shareholders who should avoid voting: None
- Proposals involving preference shareholders’ participation in voting: None
3. Things to note when voting at the general meeting of shareholders
(1) The shareholders of the Company who exercise their voting rights through the online voting system of the Shanghai Stock Exchange’s general meeting of shareholders can either log in to the trading system voting platform (through the trading terminal of the securities company designated for trading) to vote, or log in to the Internet voting platform (website: vote.sseinfo.com) to vote. When logging into the Internet voting platform to vote for the first time, investors need to complete shareholder identity authentication. For specific operations, please see the instructions on the Internet voting platform website.
(2) In order to better serve the majority of small and medium-sized investors, ensure that small and medium-sized investors who are willing to vote can participate in the meeting in a timely manner and facilitate voting. The company plans to use the shareholder meeting reminder service provided by SSE Information Network Co., Ltd. (hereinafter referred to as "SSE Information"), and entrust SSE Information to proactively remind shareholders to participate in the meeting and vote based on the shareholder list on the equity registration date through smart text messages and other forms, and actively push information such as invitations to participate in the shareholders' meeting and resolutions to each investor. After receiving the smart text message, investors can vote directly according to the prompts in the "User Manual of One-Click Online Voting Service for Listed Company Shareholders Meetings" (download link: https://vote.sseinfo.com/i/yjt_help.pdf). In case of congestion, etc., they can still vote through the original trading system voting platform and Internet voting platform.
(3) For a shareholder holding multiple shareholder accounts, the number of exercisable voting rights is the total number of common shares of the same category and preference shares of the same variety held by all shareholder accounts under his or her name.
Shareholders holding multiple shareholder accounts who participate in online voting at the general meeting of shareholders through the Exchange’s online voting system can participate through any of their shareholder accounts. After the voting, it shall be deemed that all ordinary shares of the same category and preferred shares of the same variety under all shareholder accounts have voted with the same opinion.
If a shareholder holding multiple shareholder accounts votes repeatedly through multiple shareholder accounts, the voting opinions of the same class of ordinary shares and the same type of preferred stocks under all shareholder accounts shall be based on the first voting results of each class and type of stocks respectively.
(4) If the same voting right is voted repeatedly through on-site, online voting platform of the Exchange or other methods, the result of the first vote shall prevail.
(5) Shareholders must vote on all proposals before they can be submitted.
4. Participants at the meeting
(1) Shareholders of the company who are registered in the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. after the market close on the equity registration day have the right to attend the general meeting of shareholders (see the table below for details), and may entrust a proxy in writing to attend the meeting and participate in voting. The agent does not have to be a shareholder of the company.
Share class Stock code Stock abbreviation Equity registration date
A shares 600518 Kangmei Pharmaceutical 2025/12/19
(2) Directors, supervisors and senior managers of the company.
(3) Lawyers hired by the company.
(4) Elected independent directors and other personnel
5. Meeting registration method
(1) Individual shareholders must carry out registration procedures with their ID cards, valid shareholding certificates, etc.;
(2) Legal person shareholders must carry out registration procedures with a copy of their business license (with official seal), proof of shareholding, power of attorney for the legal representative and ID card of the person attending;
(3) Shareholders who are unable to attend the meeting for any reason can entrust others to attend the meeting in writing (the power of attorney is attached). The agent must present his or her ID card, power of attorney, and shareholding certificate to complete the registration procedures; shareholders and shareholders' agents attending the meeting are requested to go to the Securities Affairs Department of the company's Shenzhen office building on December 22, 2025 (9:00-11:30 a.m., 14:00-17:00 p.m.) to go through the registration procedures. Shareholders from other places can register by letter or email, but the originals and copies of the above documents must be produced when attending the meeting to be valid.
6. Other matters
This general meeting of shareholders will last for half a day. Those attending the meeting will be responsible for their own expenses such as transportation, food and accommodation.
Contact address: Kangmei Pharmaceutical, No. 3, Taike Road, Xiameilin, Futian District, Shenzhen City, Guangdong Province
Contact person: Securities Affairs Department
Contact number: 0755-33187777
Email: [email protected]
Announcement is hereby made.
Board of Directors of Kangmei Pharmaceutical Co., Ltd.
December 11, 2025 Attachment 1: Power of Attorney
Power of attorney
Kangmei Pharmaceutical Co., Ltd.:
I hereby authorize Mr. (Ms.) to represent the company (or myself) at your company’s 2025 second extraordinary general meeting of shareholders to be held on December 26, 2025, and to exercise voting rights on your behalf. Number of common shares held by the client:
Client shareholder account number:
Serial number Name of the non-cumulative voting motion Agree Oppose Abstain 1 "Proposal on the abolition of the Supervisory Board and the abolition of the "Supervisory Board Rules of Procedure"
2 "Proposal on Amending the Articles of Association"
3 "Proposal on Amending the Rules of Procedure for the General Meeting of Shareholders"
4 "Proposal on Amending the Rules of Procedure of the Board of Directors"
5 "Proposal on Amending the "Independent Director System""
6 "Proposal on Amending the Related Party Transaction Management System"
7 "Proposal on Amending the "Statistical System for Related Party Transaction Data""
8 "Proposal on Amending the "Foreign Investment Management System""
9 "Proposal on Amending the "External Guarantee Management System""
10 "Proposal on Amending the "Raised Funds Management System""
11 "Proposal on Amending the Implementation Rules of the Cumulative Voting System"
12 "Proposal on Amending the "Internal Accountability Management System for Securities Violations and Violations" 13 "Proposal on Amending the "Accounting Firm Selection and Recruitment System"
14 "Proposal on formulating the "Remuneration Management System for Directors and Senior Management Personnel" 15 "Proposal on formulating the "Resignation Management System for Directors and Senior Management Personnel" 16 "Proposal on the Electing of Ms. Yu Yuying as an Independent Director"
Signature (stamped) of the principal: Signature of the trustee: Identity card number of the principal: Identity card number of the trustee:
Commission date: year month day
Note: The client should choose one of the "agree", "objection" or "abstain" intentions in the power of attorney and tick "√". If the client does not give specific instructions in this power of attorney, the trustee has the right to vote according to his own wishes.